After completing this education activity, the learner will be able to discuss the importance of providing patient education regarding the need for anticoagulant therapy, anticoagulant mechanism of action, adverse effects, required monitoring parameters, and need for treatment adherence to prevent stroke and thromboembolic events.
Contact hours available until 12/31/2023.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online NCPD evaluation.
Authors Conflict of Interest Disclosure:
The author(s), editor, editorial committee, content reviewers, and education director reported no actual or potential conflict of interest in relation to this nursing continuing professional development article.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
This education activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ) and the Academy of Medical-Surgical Nurses (AMSN).
Anthony J Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
Anthony J. Jannetti, Inc. is an approved provider of continuing nursing education by the California Board of Registered Nurses, Provider Number CEP 5387.
This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN, NPD-BC, AMSN Education Director.
You must be logged in and own this product in order to post comments.
Easy to read/understand.
Med surg nurses do have to be aware of anticoagulation in AF patients and especially monitoring PT INR if coumadin is in use.
Medical-surgical nurses have the knowledge and skills to advocate for positive outcomes and safety in patients with AF who take anticoagulants for stroke prevention
I will be using this article from my paper and electronic device as reference as I have not yet heard of the drug Savaysa. The article is quite informative.
Often have patients with afib. Article very informative
Great review of AF and stroke